|
AMD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.7715611723761E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.32587340685131E-15 |
| Normal-vs-Stage2 |
1.81776815821877E-12 |
| Normal-vs-Stage3 |
1.3988810110277E-14 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
8.607000E-01 |
| Stage1-vs-Stage3 |
9.300400E-01 |
| Stage1-vs-Stage4 |
5.234500E-02 |
| Stage2-vs-Stage3 |
9.240000E-01 |
| Stage2-vs-Stage4 |
1.470190E-01 |
| Stage3-vs-Stage4 |
9.599800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63402624764331E-12 |
| Normal-vs-AfricanAmerican |
2.77979861351696E-11 |
| Normal-vs-Asian |
1.62625468647093E-12 |
| Caucasian-vs-AfricanAmerican |
4.048000E-01 |
| Caucasian-vs-Asian |
2.129800E-01 |
| AfricanAmerican-vs-Asian |
1.256610E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62569957495862E-12 |
| Normal-vs-Female |
1.21014309684142E-14 |
| Male-vs-Female |
1.867420E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63280500231622E-12 |
| Normal-vs-Age(41-60Yrs) |
4.9960036108132E-15 |
| Normal-vs-Age(61-80Yrs) |
1.6269208202857E-12 |
| Normal-vs-Age(81-100Yrs) |
9.181600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.136200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.607600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.762200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.083600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.967600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.783800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.783450E-01 |
| Classical-VS-Follicular |
6.482000E-01 |
| Classical-VS-Other |
3.608200E-01 |
| Classical-VS-Normal |
1.6787682355357E-12 |
| Tall-VS-Follicular |
3.498200E-01 |
| Tall-VS-Other |
7.983800E-01 |
| Tall-VS-Normal |
6.21724893790088E-15 |
| Follicular-VS-Other |
5.588600E-01 |
| Follicular-VS-Normal |
1.66655578226482E-12 |
| Other-VS-Normal |
7.28139992745014E-10 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.9960036108132E-15 |
| Normal-vs-N1 |
1.62814206561279E-12 |
| N0-vs-N1 |
5.475800E-01 |
|
|
